Thematic Investing Brings PE to the Clinical Trials Market
COVID-19 shone a light on a fragmented market. Now private equity firms are building platforms of clinical site businesses with an eye toward improving diversity.
Latest News
A Pathway to Resilience: Reshoring Shapes PE’s Manufacturing Strategy
TBM Consulting shares considerations for PE investors in manufacturing as reshoring efforts grow
The Changing Face of Media Liability Risk
This episode is brought to you by QBE North America, a global insurance leader focused on helping customers solve unique risks to enable a more resilient future
PE Weekly: Focus Turns to the Lower-Middle Market
M&A finds value and opportunity in the lower end of the middle-market
On the Move: March 2023 Hires and Promotions
New hires and promotions within investment banks, private equity firms, lenders, law firms and more
From Golf to Negotiation: ACG’s Women’s Groups Are Closing the M&A Gender Divide
A look at the women of ACG working to promote the success of their female peers, share their stories and close the gender gap in middle-market dealmaking
Doing Diligence Right: How to Protect and Drive Deal Value in Disrupted M&A Markets
Why this year, acquirers must take a different, more integrated approach to due diligence
The Middle Market in 2023: A Conversation with Nancy Giordano
Strategic futurist, Play Big, Inc. founder and DealMAX keynote speaker Nancy Giordano shares her outlook for the middle market
PE Weekly: Private Equity Leads the ESG Pack
New research finds PE is a leader in ESG management as investors this week target clean energy
Reputational Due Diligence: Cautionary Tales in M&A
Shedding light on the importance of considering the reputation of a business and its people during M&A due diligence